Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 316082, 8 pages
http://dx.doi.org/10.1155/2014/316082
Research Article

Synthesis and Antimicrobial Activities of 5-Arylidene-thiazolidine-2,4-dione Derivatives

1Department of Pharmacy, Federal University of Pernambuco, Avenida Professor Moraes Rego 1235, Cidade Universitária, 50670-901 Recife, PE, Brazil
2Department of Antibiotics, Federal University of Pernambuco, Avenida Professor Moraes Rego 1235, Cidade Universitária, 50670-901 Recife, PE, Brazil

Received 27 February 2014; Revised 14 April 2014; Accepted 15 April 2014; Published 7 May 2014

Academic Editor: Terry K. Smith

Copyright © 2014 Ivanildo Mangueira da Silva et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Verma and S. K. Saraf, “4-Thiazolidinone—a biologically active scaffold,” European Journal of Medicinal Chemistry, vol. 43, no. 5, pp. 897–905, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. J. Andres, J. J. Bronson, S. V. D'Andrea et al., “4-Thiazolidinones: novel inhibitors of the bacterial enzyme MurB,” Bioorganic & Medicinal Chemistry Letters, vol. 10, no. 8, pp. 715–717, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Tunçbilek and N. Altanlar, “Synthesis and antimicrobial evaluation of some 3-(substituted phenacyl)-5-[4′-(4H-4-oxo-1-benzopyran-2-yl)-benzylidene]-2,4- thiazolidinediones,” Il Farmaco, vol. 54, no. 7, pp. 475–478, 1999. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Devinyak, D. Havrylyuk, B. Zimenkovsky, and R. Lesyk, “Computational search for possible mechanisms of 4-thiazolidinones anticancer activity: the power of visualization,” Molecular Informatics, vol. 33, no. 3, pp. 216–229, 2014. View at Publisher · View at Google Scholar
  5. T. Tomašić and L. P. Mašič, “Rhodanine as a privileged scaffold in drug discovery,” Current Medicinal Chemistry, vol. 16, no. 13, pp. 1596–1629, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. M. C. Andrade, W. T. Lima, M. P. A. Rocha et al., “Synthesis and structural study of substituted thioxothiazolidinones and thioxoimidazolidinones,” Bollettino Chimico Farmaceutico, vol. 141, no. 6, pp. 428–433, 2002. View at Google Scholar · View at Scopus
  7. T. Tomašić, N. Zidar, A. Kovač et al., “5-benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases,” ChemMedChem, vol. 5, no. 2, pp. 286–295, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. S. A. El-Gaby, G. A. M. El-Hag Ali, A. A. El-Maghraby, M. T. Abd El-Rahman, and M. H. M. Helal, “Synthesis, characterization and in vitro antimicrobial activity of novel 2-thioxo-4-thiazolidinones and 4,4′-bis(2-thioxo-4-thiazolidinone-3-yl)diphenylsulfones,” European Journal of Medicinal Chemistry, vol. 44, no. 10, pp. 4148–4152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. R. B. Lesyk, B. S. Zimenkovsky, D. V. Kaminskyy et al., “Thiazolidinone motif in anticancer drug discovery. Experience of DH LNMU medicinal chemistry scientific group,” Biopolymers and Cell, vol. 27, no. 2, pp. 107–117, 2011. View at Google Scholar · View at Scopus
  10. A. A. R. Silva, A. J. da Silva Góes, W. T. de Lima, and M. B. de Souza Maia, “Antiedematogenic activity of two thiazolidine derivatives: N-tryptophyl-5-(3,5-di-tert-butyl-4-hydroxybenzylidene) rhodanine (GS26) and N-tryptophyl-5-(3,5-di-tert-butyl-4-hydroxybenzylidene)-2,4-thiazolidinedione (GS28),” Chemical and Pharmaceutical Bulletin, vol. 51, no. 12, pp. 1351–1355, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Tomašić and L. P. Masic, “Prospects for developing new antibacterials targeting bacterial type IIA topoisomerases,” Current Topics in Medicinal Chemistry, vol. 14, no. 1, pp. 130–151, 2014. View at Google Scholar
  12. F. L. Gouveia, R. M. B. de Oliveira, T. B. de Oliveira et al., “Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones,” European Journal of Medicinal Chemistry, vol. 44, no. 5, pp. 2038–2043, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Ottanà, R. MacCari, M. L. Barreca et al., “5-Arylidene-2-imino-4-thiazolidinones: design and synthesis of novel anti-inflammatory agents,” Bioorganic and Medicinal Chemistry, vol. 13, no. 13, pp. 4243–4252, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. P. Vicini, A. Geronikaki, K. Anastasia, M. Incerti, and F. Zani, “Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones,” Bioorganic and Medicinal Chemistry, vol. 14, no. 11, pp. 3859–3864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Tavares, Manual de Antibióticos e Quimioterápicos Anti-Infecciosos, Atheneu, São Paulo, Brazil, 3th edition, 2002.
  16. K. Babaoglu, M. A. Page, V. C. Jones et al., “Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis,” Bioorganic and Medicinal Chemistry Letters, vol. 13, no. 19, pp. 3227–3230, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. J. Tortora and B. R. Funke, Microbiologia, Artes Médicas Sul, Porto Alegre, Brazil, 6th edition, 2003.
  18. O. Bozdaǧ-Dündar, Ö. Özgen, A. Menteşe et al., “Synthesis and antimicrobial activity of some new thiazolyl thiazolidine-2,4-dione derivatives,” Bioorganic and Medicinal Chemistry, vol. 15, no. 18, pp. 6012–6017, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Gumbo, “General principles of antimicrobial therapy,” in Goodman & Gilman’s The Pharmacological Basis of Therapeutics, L. L. Brunton, B. A. Chabner, and B. C. Knollmann, Eds., McGraw-Hill, 12th edition, 2012. View at Google Scholar
  20. I. Chopra, C. Schofield, M. Everett et al., “Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement,” The Lancet Infectious Diseases, vol. 8, no. 2, pp. 133–139, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Malik, P. K. Upadhyaya, and S. Miglani, “Thiazolidinediones: a plethro of biological load,” International Journal of PharmTech Research, vol. 3, no. 1, pp. 62–75, 2011. View at Google Scholar · View at Scopus
  22. S. Allen, B. Newhouse, A. S. Anderson et al., “Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists,” Bioorganic and Medicinal Chemistry Letters, vol. 14, no. 7, pp. 1619–1624, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” The American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966. View at Google Scholar · View at Scopus
  24. Clinical and Laboratory Standards Institute (CLSI), Performance Standards for Antimicrobial Disk Susceptibility Tests, 23rd informational supplement M100-S23, Clinical and Laboratory Standards Institute (CLSI), Wayne, Pa, USA, 2013.
  25. M. Tunçbilek, O. Bozdag-Dündar, G. Ayhan-Kilcigil et al., “Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives—fifth communication: Flavonyl benzyl substituted 2,4-thiazolidinediones,” Il Farmaco, vol. 58, no. 1, pp. 79–83, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Bruno, L. Costantino, C. Curinga et al., “Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones,” Bioorganic and Medicinal Chemistry, vol. 10, no. 4, pp. 1077–1084, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Kocabalkanli, Ö. Ates, and G. Ötük, “Synthesis of Mannich bases of some 2, 5-disubstituted 4-thiazolidinones and evaluation of their antimicrobial activities,” Archiv der Pharmazie, vol. 334, no. 2, pp. 35–39, 2001. View at Google Scholar
  28. N. Zidar, T. Tomašić, R. Šink et al., “New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation,” European Journal of Medicinal Chemistry, vol. 46, no. 11, pp. 5512–5523, 2011. View at Publisher · View at Google Scholar · View at Scopus